Stay connected:
Material on this website is © 2012 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Recently blogged
Life sciences
At the forefront of a changing industry
Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's most pressing challenges. The Life Sciences and Health Care industry group understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life. As technology, government, and research shape the evolution of the life sciences industry, Deloitte's global network can help clients address today's challenges and prepare for the future. To learn more about Deloitte's global industry practice and the services offered to clients, contact the LSHC group.
 |
Focus: The pharmaceutical innovation dilemma Pharma innovation is facing a fundamental productivity challenge. Investment in R&D has outpaced sales growth, but this has not increased output of new medicines. Execs are seeking greater transparency in R&D decision making. |
|
 |
The next phase: Opportunities in China's pharmaceuticals market This Deloitte China report focuses on pharmaceuticals companies, both domestic and foreign, and their activities in the China market—all from the viewpoint of prospective investors. |
|
 |
Measuring the return from innovation: Is R&D earning its investment? R&D leaders in the life sciences industry are under continued pressure to justify the investment in R&D. Deloitte and Thomson Reuters collaborated in producing this annual review of R&D returns in life sciences. |
|
 |
CBI Pharma/Biotech Accounting & Reporting Congress 2012 Deloitte is proud to again serve as the Lead Summa sponsor for this prestigious conference for financial and accounting executives in the life sciences industry. |
|
